Related references
Note: Only part of the references are listed.Growth Arrest-Specific 6 (Gas6) and TAM Receptors in Mouse Platelets
Fikriye Uras et al.
TURKISH JOURNAL OF HEMATOLOGY (2015)
Assessment of arterial stiffness and cardiovascular hemodynamics by oscillometric method in psoriasis patients with normal cardiac functions
Murat Sunbul et al.
HEART AND VESSELS (2015)
Aortic Arterial Stiffness is a Moderate Predictor of Cardiovascular Disease in Patients With Psoriasis Vulgaris
Ilknur Balta et al.
ANGIOLOGY (2014)
Psoriasis and Atherosclerosis: Is There a Need For Novel Biomarkers Assessing Cardiovascular Risk?
Murat Sunbul et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Tyro3, Axl, and Mertk Receptor Signaling in Inflammatory Bowel Disease and Colitis-associated Cancer
Carla V. Rothlin et al.
INFLAMMATORY BOWEL DISEASES (2014)
Expression of growth arrest-specific protein 6 and Axl molecules in the left internal mammary artery of patients undergoing coronary artery bypass grafting
Chien-Hsing Lee et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study
H. Montaudie et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Association of plasma growth arrest-specific protein 6 (Gas6) concentrations with albuminuria in patients with type 2 diabetes
Aybala Erek-Toprak et al.
RENAL FAILURE (2014)
The expression of TAM receptors and their ligand Gas6 is downregulated in psoriasis
Andras Szasz et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2013)
Plasma Concentrations Predict Aortic Expression of Growth-Arrest-Specific Protein 6 in Patients Undergoing Coronary Artery Bypass Grafting
Chien-Hsing Lee et al.
PLOS ONE (2013)
Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity
Pedro Recarte-Pelz et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the United Kingdom
Sinead M. Langan et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Psoriasis and cardiovascular risk factors: A case-control study on inpatients comparing psoriasis to dermatitis
Jonathan Shapiro et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Increased secretion of Gas6 by smooth muscle cells in human atherosclerotic carotid plaques
Sylvain Clauser et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Growth Arrest-Specific Gene 6 (gas6) and Vascular Hemostasis
Sandrine Laurance et al.
ADVANCES IN NUTRITION (2012)
Determination of subclinical atherosclerosis in plaque type psoriasis patients without traditional risk factors for atherosclerosis
Emre Refik Altekin et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events
Nehal N. Mehta et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Association of Warfarin Use With Valvular and Vascular Calcification: A Review
Chandrasekar Palaniswamy et al.
CLINICAL CARDIOLOGY (2011)
Psoriasis and Vascular Disease-Risk Factors and Outcomes: A Systematic Review of the Literature
Rita V. Patel et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2011)
Genome-Wide Expression Profiling of Five Mouse Models Identifies Similarities and Differences with Human Psoriasis
William R. Swindell et al.
PLOS ONE (2011)
Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus
Carl Ekman et al.
RHEUMATOLOGY (2011)
Psoriasis and cardiovascular disease
Gino A. Vena et al.
DERMATOLOGIC THERAPY (2010)
TAM receptor ligands in lupus: Protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus
Chang-Hee Suh et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Plasma Level of Growth Arrest-Specific 6 (GAS6) Protein and Genetic Variations in the GAS6 Gene in Patients With Acute Coronary Syndrome
Lei Jiang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes
Marc Tjwa et al.
BLOOD (2008)
Vitamin K-dependent proteins, warfarin, and vascular calcification
John Danziger
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Immunobiology of the TAM receptors
Greg Lemke et al.
NATURE REVIEWS IMMUNOLOGY (2008)
TAM receptors are pleiotropic inhibitors of the innate immune response
Carla V. Rothlin et al.
CELL (2007)
Pathogenesis and therapy of psoriasis
Michelle A. Lowes et al.
NATURE (2007)
Gas6/Ax1-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells
Bo-Kyung Son et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Growth arrest-specific protein 6 plasma concentrations during septic shock
Sebastien Gibot et al.
CRITICAL CARE (2007)
The immune response in atherosclerosis: a double-edged sword
Goran K. Hansson et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis
D Borgel et al.
CRITICAL CARE MEDICINE (2006)
Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis
MJ Peters et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2004)
Immunopathogenic mechanisms in psoriasis
JE Gudjonsson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Macrophage regulation by Tyro 3 family receptors
G Lemke et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
A Angelillo-Scherrer et al.
NATURE MEDICINE (2001)
Share Paper
